A vaccine consisting of inactivated poliovirus (IPV) types 1, 2, and 3, with active immunizing activity against poliomyelitis. Upon intramuscular vaccination, inactivated poliovirus vaccine (IPV) activates the immune system to develop antibodies against polio viruses. The rabies vaccine is a vaccine used to prevent rabies. There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies before, and, for some time, after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite. Governments around the world are actively working towards eradicating polio, which has led to increased demand for IPV. Additionally, the rising prevalence of polio in certain regions, such as the North America region, has also contributed to the growth of this segment. The increasing prevalence of polio and rabies diseases is driving the growth of the inactivated polio and the rabies vaccine associated with the virus is expected to boost the global inactivated polio and rabies vaccine market growth.
Market Dynamics
Research and development activity by market players is expected to spur the global inactivated polio and rabies vaccines market growth over the forecast period. For Instance, in March 2021, Ocugen Inc., is a biotech company in the U.S., announced positive top-line data for rabies, polio and COVID-19 Vaccine. Investigational vaccine that uses the same vero cell manufacturing platform that had been used in the production of polio vaccines for decades.
Key features of the study:
- This report provides an in-depth analysis of the global inactivated polio and rabies vaccines market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global inactivated polio and rabies vaccines market based on the following parameters–Company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Bharat Biotech., BIO-MED, Serum Institute of India Pvt. Ltd., Kedrion Biopharma Inc. GlaxoSmithKline plc., Bilthoven Biologicals, Merck & Co., Inc., Pfizer Inc, Cadila Healthcare Limited, Sanofi Pasteur India Pvt Ltd, Chiron Behring Vaccines Private Ltd ,Zoetis Inc., Elanco.,Boehringer Ingelheim International GmbH,Indian Immunologicals Ltd, Wyeth pharmaceuticals, Berna Biotech Ltd., Novartis Vaccines Ltd and Medimmune LLC.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global inactivated polio and rabies vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Ultrasound Bladder Scanner market
Detailed Segmentation:
- Global Inactivated Polio And Rabies Vaccines Market, By Product Type:
- Inactivated Polio Vaccine
- Inactivated Rabies Vaccine
- Global Inactivated Polio And Rabies Vaccines Market, By Method of Inactivation:
- Radiation Method
- Heat Inactivation
- Solvent Detergent Method
- pH Concentration
- Health Activation
- Others
- Global Inactivated Polio And Rabies Vaccines Market, By Age Group:
- Global Inactivated Polio And Rabies Vaccines Market, By Distribution Channel:
- Global Inactivated Polio And Rabies Vaccines Market, By Region:
- North America
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Bharat Biotech.
- BIO-MED
- Serum Institute of India Pvt. Ltd.
- Kedrion Biopharma Inc.
- GlaxoSmithKline plc..
- Bilthoven Biologicals.
- Merck & Co.
- Pfizer Inc.
- Cadila Healthcare Limited
- Sanofi Pasteur India Pvt Ltd
- Chiron Behring Vaccines Private Ltd
- Zoetis Inc.
- Boehringer Ingelheim International GmbH
- Indian Immunologicals Ltd
- Wyeth pharmaceuticals
- Berna Biotech Ltd.
- Novartis Vaccines Ltd
- Medimmune LLC.
